Novo Nordisk Announces $4 Billion Expansion to Meet Rising Ozempic Demand in the US
Novo Nordisk's market worth exceeds that of Denmark as a whole, and its shares have increased ...
Novo Nordisk's market worth exceeds that of Denmark as a whole, and its shares have increased ...
Stelo will be the first glucose biosensor in the US certified for non-prescription use. It's designed ...
Ozempic's unparalleled weight-loss effects swiftly captured global attention In 2022, Novo Nordisk, a Danish pharmaceutical company, ...
Health insurer Cigna is facilitating an expansion of its Medicare Advantage plans, for the third consecutive ...
The leading biopharmaceutical company AstraZeneca India signed a memorandum of understanding with Docon Technologies, Bangalore, India. ...
The Global Economics Limited is a UK based financial publication and a Bi-Monthly business magazine giving thoughtful insights into the financial sectors on various industries across the world. Our highlight is the prestigious country specific Annual Global Economics awards program where the best performers in various financial sectors are identified worldwide and honoured.
All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏
All Rights Reserved © 2020 | 🇬🇧 The Global Economics, Business Finance Publication - www.theglobaleconomics.uk 🌏